Clinical and epidemiological predictors of recurrent cytomegalovirus disease in orthotopic liver transplant recipients

Clinical Infectious Diseases

Volumn 25, Issue 2, 1997, Pages 314-317

  Falagas, Matthew E ^a   Snydman, David R ^a,b   Griffith, John ^a   Werner, Barbara G ^a   Freeman, Richard ^a   Rohrer, Richard ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR;

ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DEATH; HUMAN; LIVER TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; VIRUS PNEUMONIA;

EID: 0030878060     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514555     Document Type: Article

References (7)

1. Dunn DL, Mayoral JL, Gillingham KJ, et al. Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir. Transplantation 1991;51(1):98-106.
2. Stratta RJ, Shaefer MS, Markin RS, et al. Clinical patterns of cytomegalovirus disease after liver transplantation. Arch Surg 1989;124:1443-50.
3. Sawyer MD, Mayoral JL, Gillingham KJ, Kramer MA, Dunn DL. Treatment of recurrent cytomegalovirus disease in patients receiving solid organ transplants. Arch Surg 1993;128:165-70.
4. Falagas ME, Snydman DR. Recurrent cytomegalovirus disease in solidorgan transplant recipients. Transplant Proc 1995;27(suppl l):34-7.
5. Hibberd PL, Basgoz N, Fishman J, Rubin RH. Primary cytomegalovirus (CMV) disease is a risk factor for recurrent CMV disease in transplant recipients [abstract no H28]. In: Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (Orlando). Washington, DC: American Society for Microbiology, 1994:136.
6. Snydman DR, Werner BG, Dougherty NN, et al. Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1993;119: 984-91.
7. Boivin G, Erice A, Crane DD, Dunn DL, Balfour HH Jr. Ganciclovir susceptibilities of Cytomegalovirus (CMV) isolates from solid organ transplant recipients with CMV viremia after antiviral prophylaxis. J Infect Dis 1993;168:332-5.